Product NDC: | 52544-295 |
Proprietary Name: | Amethyst |
Non Proprietary Name: | Levonorgestrel and Ethinyl Estradiol |
Active Ingredient(s): | 20; 90 ug/1; ug/1 & nbsp; Levonorgestrel and Ethinyl Estradiol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52544-295 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079218 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110613 |
Package NDC: | 52544-295-28 |
Package Description: | 1 BLISTER PACK in 1 CARTON (52544-295-28) > 28 TABLET in 1 BLISTER PACK |
NDC Code | 52544-295-28 |
Proprietary Name | Amethyst |
Package Description | 1 BLISTER PACK in 1 CARTON (52544-295-28) > 28 TABLET in 1 BLISTER PACK |
Product NDC | 52544-295 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levonorgestrel and Ethinyl Estradiol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110613 |
Marketing Category Name | ANDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | ETHINYL ESTRADIOL; LEVONORGESTREL |
Strength Number | 20; 90 |
Strength Unit | ug/1; ug/1 |
Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |